Darusentan
Darusentan (LU-135252) is a potent and selective endothelin receptor antagonist. It is used in research to study endothelin-mediated vasoconstriction in cardiovascular diseases, with applications in both in vitro assays and in vivo hypertension models.
Product Specifications
CAS Number
171714-84-4
Product Name Alternative
Darusentan, aortic, inhibit, muscle, Lu135252, Lu-135252, Lu 135252, Inhibitor, Endothelin Receptor, endothelin, Endothelin A receptor, EndothelinReceptor, ET-A, rat, receptor, RAVSMs, smooth, vascular
Field of Research
Pharmacology & Drug Discovery
Purity
97.26% (May vary between batches)
Solubility
10% DMSO+40% PEG300+5% Tween 80+45% Saline:4 mg/mL (9.75 mM) ; H2O:Insoluble; DMSO:125 mg/mL (304.56 mM)
Smiles
COc1cc (OC) nc (O[C@H] (C (O) =O) C (OC) (c2ccccc2) c2ccccc2) n1
Molecular Formula
C22H22N2O6
Molecular Weight
410.43
Storage Conditions
-20°C
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
A32839-Cy3 100 µg/Vial
Anti-NADH2/Mtnd2 Antibody Picoband®, Cy3 Conjugate
Sign In for Pricing
View Details 